|Primary analysis complete
|Study Start Date:
|Study Made Public:
A Phase Ib randomized double-blind clinical trial to examine whether polytopic administration of VRC rAd5 Gag/Pol, Env A/B/C vaccine enhances HIV-specific cellular immune responses in humans
HVTN 085 is a Phase Ib clinical trial to evaluate the safety and immunogenicity of combinations of rAd5 (VRCHIVADV014-00-VP, VRCHIVADV038-00-VP, VRCHIVADV052-00-VP, VRCHIVADV053-00-VP, and VRCHIVADV054-00-VP).
Sign in to see full information about this study and to download study data.
ProductsProduct info coming soon!
No integrated data is available for this study.
No non-integrated data is available for this study.